-
-
-
-
-
-
-
Precigen Inc. (PGEN) PT Raised to $11 at Citizens on Above Estimate Q1 Results
-
-
-
-
-
-
-
Precigen reports 200 patients enrolled for FDA-approved RRP therapy
-
-
-
-
-
-
-
Cantor Fitzgerald Reiterates Overweight Rating on Precigen Inc. (PGEN)
-
-
-
-
-
-
-
Stifel Reiterates Buy Rating on Precigen Inc. (PGEN)
-
-
-
-
-
-
-
Stifel Highlights Iovanace Biotherapeutics (IOVA) as 'Top Pick' in Biotech's 2025 Outlook Note
-
-
-
-
-
-
-
Precigen Inc. (PGEN) Announces Proposed $30M Share Offering
-
446,446 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

